Ross Moat Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Ross Moat is CHIEF CORP. & COMM. OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 9,415 shares of KNSA, which is worth approximately $379,612. The most recent transaction as insider was on Sep 04, 2025, when has been sold 3,523 shares (Class A Ordinary Share) at a price of $35.31 per share, resulting in proceeds of $124,397. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.42K

0% 3M change

56.68% 12M change

Total Value Held $379,612

Ross Moat Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2025	SELL Open market or private sale	$124,397 $35.31 p/Share	3,523 Reduced 27.23%	9,415 Class A Ordinary Share
Sep 02 2025	SELL Payment of exercise price or tax liability	$16,488 $34.28 p/Share	481 Reduced 3.58%	12,938 Class A Ordinary Share
Sep 02 2025	BUY Exercise of conversion of derivative security	-	994 Added 6.9%	13,419 Class A Ordinary Share
Sep 01 2025	SELL Payment of exercise price or tax liability	$94,408 $33.49 p/Share	2,819 Reduced 18.49%	12,425 Class A Ordinary Share
Sep 01 2025	BUY Exercise of conversion of derivative security	-	5,829 Added 27.66%	15,244 Class A Ordinary Share
Jun 03 2025	SELL Open market or private sale	$800,777 $29.02 p/Share	27,594 Reduced 74.56%	9,415 Class A Ordinary Share
Jun 03 2025	BUY Exercise of conversion of derivative security	$368,379 $13.35 p/Share	27,594 Added 42.71%	37,009 Class A Ordinary Share

May 05 2025	SELL Open market or private sale	$175,616 $28.0 p/Share	6,272 Reduced 39.98%	9,415 Class A Ordinary Share
May 05 2025	BUY Exercise of conversion of derivative security	$111,390 $17.76 p/Share	6,272 Added 28.56%	15,687 Class A Ordinary Share
May 02 2025	SELL Open market or private sale	$107,800 $28.0 p/Share	3,850 Reduced 29.02%	9,415 Class A Ordinary Share
May 02 2025	BUY Exercise of conversion of derivative security	$68,376 $17.76 p/Share	3,850 Added 22.49%	13,265 Class A Ordinary Share
May 01 2025	SELL Open market or private sale	$651,016 $28.02 p/Share	23,234 Reduced 71.16%	9,415 Class A Ordinary Share
May 01 2025	BUY Exercise of conversion of derivative security	$326,902 $14.07 p/Share	23,234 Added 41.58%	32,649 Class A Ordinary Share
Apr 29 2025	SELL Open market or private sale	$1,614,322 $25.21 p/Share	64,035 Reduced 87.18%	9,415 Class A Ordinary Share
Apr 29 2025	BUY Exercise of conversion of derivative security	$854,226 $13.34 p/Share	64,035 Added 46.58%	73,450 Class A Ordinary Share
Apr 21 2025	SELL Open market or private sale	$370,475 $20.29 p/Share	18,259 Reduced 65.98%	9,415 Class A Ordinary Share
Apr 07 2025	SELL Payment of exercise price or tax liability	$14,743 $20.28 p/Share	727 Reduced 2.56%	27,674 Class A Ordinary Share
Apr 07 2025	BUY Exercise of conversion of derivative security	-	2,477 Added 8.02%	28,401 Class A Ordinary Share
Apr 01 2025	SELL Payment of exercise price or tax liability	$21,421 $21.77 p/Share	984 Reduced 3.66%	25,924 Class A Ordinary Share
Apr 01 2025	BUY Exercise of conversion of derivative security	-	3,352 Added 11.08%	26,908 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$6,602 $22.61 p/Share	292 Reduced 1.22%	23,556 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	994 Added 4.0%	23,848 Class A Ordinary Share
Jan 15 2025	BUY Grant, award, or other acquisition	$17,888 $16.0 p/Share	1,118 Added 4.66%	22,854 Class A Ordinary Share
Sep 03 2024	SELL Open market or private sale	$1,822,944 $26.61 p/Share	68,506 Reduced 75.91%	21,736 Class A Ordinary Share
Sep 03 2024	BUY Exercise of conversion of derivative security	$728,218 $10.63 p/Share	68,506 Added 43.15%	90,242 Class A Ordinary Share

Ross Moat

CHIEF CORP. & COMM. OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account